πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 311 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 11459360

Recombinant HIV-1 envelope proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11401341

Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic canc

PRECISION BIOLOGICS, INC. Β· Granted Tue Aug 02 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11396540

Methods for making recombinant proteins

Coherus BioSciences, Inc. Β· Granted Tue Jul 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 21 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11332721

Recombinant respiratory syncytial virus strains with mutations in the M2-2 ORF providing a

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue May 17 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11305009

Recombinant virus with diminished latency and methods of using same

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Apr 19 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 14 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11299517

Recombinant vaccine against Marek's disease and Newcastle disease

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue Apr 12 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 07 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11273214

Recombinant chimeric bovine/human parainfluenza virus 3 expressing RSV G and its use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11254731

Viral vectors encoding recombinant FVIII variants with increased expression for gene thera

Takeda Pharmaceutical Company Limited Β· Granted Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11246947

Recombinant AAV-crumbs homologue composition and methods for treating LCA-8 and progressiv

Academisch Ziekenhuis Leiden h.o.d.n. Leids Universitair Medisch Centrum Β· Granted Tue Feb 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 10 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11197916

Lyophilized recombinant VWF formulations

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 14 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 09 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11191813

Lyophilized recombinant VWF formulations

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11191837

Recombinant VWF formulations

Takeda Pharmaceutical Company Limited Β· Granted Tue Dec 07 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11155804

Recombinant polypeptides comprising selenocysteine and method for producing the same

The Board of Regents of the University of Texas System Β· Granted Tue Oct 26 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 21 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11136356

Recombinant HIV-1 envelope proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Oct 05 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11104719

Recombinant clusterin and use thereof in the treatment and prevention of disease

The Board of Regents of the University of Texas System Β· Granted Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11084850

Recombinant prefusion RSV F proteins and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Aug 10 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 05 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11078257

Recombinant gram negative bacteria and methods of generating and utilizing same

THE REGENTS OF THE UNIVERSITY OF MICHIGAN Β· Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11077200

Combined enteropathogen recombinant construct

United States of America as represented by the Secretary of the Air Force Β· Granted Tue Aug 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11027008

Recombinant mumps virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11027007

Recombinant metapneumovirus F proteins and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 11000579

Recombinant Eimeria maxima protein delivered as nanoparticles

The United States of America, as represented by the Secretary of Agriculture Β· Granted Tue May 11 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10953083

Recombinant respiratory syncytial virus strains comprising NS1 and NS2 gene shifts

The United States of America, as represented by the Secretary, Department of Health and Human Services Β· Granted Tue Mar 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10844098

Method for preparing bacterial polysaccharide-modified recombinant fusion protein and use

Institute of Biotechnology, Academy of Military Medical Sciences, China Β· Granted Tue Nov 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 10829795

Method for rapid in vitro synthesis of glycoproteins via recombinant production of N-glyco

Northwestern University Β· Granted Tue Nov 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 05 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted